We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors). Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinicalโstage T-cell reprogramming company advancing a diverse pipeline of cell...
On track to report initial clinical and translational data from lead CAR T-cell and TIL product candidates in 2024Received Orphan Drug Designation for LYL845 for the treatment of melanomaExpect to...
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinicalโstage T-cell reprogramming company advancing a diverse pipeline of cell...
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinicalโstage T-cell reprogramming company advancing a diverse pipeline of cell...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -4.16666666667 | 2.4 | 2.55 | 2.15 | 932866 | 2.35054882 | CS |
4 | 0.32 | 16.1616161616 | 1.98 | 3.145 | 1.93 | 1017983 | 2.42295752 | CS |
12 | 0.39 | 20.4188481675 | 1.91 | 3.2556 | 1.69 | 930184 | 2.28210639 | CS |
26 | 0.74 | 47.4358974359 | 1.56 | 3.2556 | 1.52 | 1127480 | 2.09253838 | CS |
52 | 0.02 | 0.877192982456 | 2.28 | 3.97 | 1.32 | 1020871 | 2.31128947 | CS |
156 | -16.45 | -87.7333333333 | 18.75 | 19.84 | 1.32 | 942722 | 4.8014202 | CS |
260 | -16.45 | -87.7333333333 | 18.75 | 19.84 | 1.32 | 942722 | 4.8014202 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions